Quercetin
Showing 1 - 25 of 163
Pharmacokinetics Trial in Burnaby (Quercetin LipoMicel (250 mg), Quercetin LipoMicel (500 mg), Quercetin LipoMicel (1000 mg))
Completed
- Pharmacokinetics
- Quercetin LipoMicel (250 mg)
- +3 more
-
Burnaby, British Columbia, CanadaISURA
Nov 3, 2022
Inflammation Gum Trial (Quercetin, scaling and root planing)
Not yet recruiting
- Inflammation Gum
- Quercetin
- scaling and root planing
- (no location specified)
Jun 23, 2023
Endometriosis Trial in Tehran (Quercetin, Placebo)
Recruiting
- Endometriosis
- Quercetin
- Placebo
-
Tehran, Iran, Islamic Republic ofNational Nutrition and Food Technology Research Institute
Aug 15, 2023
COPD Trial in Philadelphia (Quercetin)
Not yet recruiting
- Chronic Obstructive Pulmonary Disease
- Quercetin
-
Philadelphia, PennsylvaniaNathaniel Marchetti
Aug 15, 2023
Schizophrenia, Treatment Resistant Depression, Aging, Premature Trial in Saint Louis (Dasatinib + quercetin)
Not yet recruiting
- Schizophrenia
- +2 more
- Dasatinib + quercetin
-
Saint Louis, MissouriWashington University School of Medicine
Apr 28, 2023
Coronary Artery Disease, Menopause Trial in Sao Paulo (Quercetin, Placebo)
Recruiting
- Coronary Artery Disease
- Menopause
- Quercetin
- Placebo
-
Sao Paulo, São Paulo, BrazilINCOR- Heart Institute
May 17, 2023
Chronic Fatigue Syndrome, Sleep, Physical Performance Trial in Pavia (Quercetin group, Placebo group)
Completed
- Chronic Fatigue Syndrome
- +3 more
- Quercetin group
- Placebo group
-
Pavia, Italyl'Istituto di Riabilitazione e cura "Santa Margherita" di Pavia,
Feb 7, 2023
Obesity, Diabetes Trial run by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (Quercetin, Placebo)
Completed
- Obesity
- Diabetes
- Quercetin
- Placebo
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 25, 2023
SARS (Severe Acute Respiratory Syndrome) Trial in Sousse, Sahloul (Quercetin, Placebo)
Completed
- SARS (Severe Acute Respiratory Syndrome)
- Quercetin
- Placebo
-
Sousse, Itinéraire Ceinture Cité Sahloul, Tunisia
- +1 more
Jan 2, 2023
Menopause Related Conditions Trial in Winston-Salem (Placebo oral soft chew, Quercetin)
Withdrawn
- Menopause Related Conditions
- Placebo oral soft chew
- Quercetin
- (no location specified)
Oct 5, 2022
Head and Neck Squamous Cell Carcinomas Trial (Tislelizumab + Dasatinib + Quercetin, surgery)
Not yet recruiting
- Head and Neck Squamous Cell Carcinomas
- Tislelizumab + Dasatinib + Quercetin
- surgery
- (no location specified)
Feb 2, 2023
Quercetin, Lipid Metabolism, Aging Trial in Summerville (Quercetin Phytosome)
Recruiting
- Quercetin
- +2 more
- Quercetin Phytosome
-
Summerville, South CarolinaThis is a remote study - participants will find a commercial lab
May 14, 2022
Breast Cancer Female, Triple Negative Breast Cancer Trial (quercetin, EGCG, metformin , zinc)
Not yet recruiting
- Breast Cancer Female
- Triple Negative Breast Cancer
- quercetin, EGCG, metformin , zinc
- (no location specified)
Dec 23, 2022
NAFLD, NASH With Fibrosis, Liver Fibrosis Trial (Dasatinib 100 MG + Quercetin (1250 MG), Placebo)
Not yet recruiting
- NAFLD
- +2 more
- Dasatinib 100 MG + Quercetin (1250 MG)
- Placebo
- (no location specified)
Aug 16, 2022
Osteoarthritis Trial (Quercetin Cap/Tab ,Fisetin Cap/Tab, Quercetin Cap/Tab,Fisetin Cap/tab,Glycyrrhizin capsules, Placebo)
Not yet recruiting
- Osteoarthritis
- Quercetin and Fisetin tab.
- +2 more
- (no location specified)
Jan 18, 2023
Osteopenia, Osteoporosis Trial in Odense (Dasatinib 100 Mg Oral Tablet, Quercetin 1.250 mg (oral), Nicotinamide Riboside 1g
Recruiting
- Osteopenia, Osteoporosis
- Dasatinib 100 Mg Oral Tablet
- +2 more
-
Odense, DenmarkOdense University Hospital
Aug 29, 2023
Osteoporosis, Postmenopausal Trial in Kennesaw (Quercetin (500 mg), Placebo (500 mg))
Completed
- Osteoporosis, Postmenopausal
- Quercetin (500 mg)
- Placebo (500 mg)
-
Kennesaw, GeorgiaKennesaw State University
May 7, 2022
Oral Cancer Trial in Cairo (Quercetin 3,3',4',5,6-Pentahydroxyflavone,
Not yet recruiting
- Oral Cancer
- Quercetin 3,3',4',5,6-Pentahydroxyflavone, 2-(3,4-Dihydroxyphenyl)-3,5,7-trihydroxy-4H-1-benzopyran-4-one
- +2 more
-
Cairo, Egypt11 Saraya El Manial
Jul 8, 2022
COVID-19 Trial in Lahore (standard of care for COVID-19 as per the hospital guidelines, Quercetin Phytosome (QP))
Completed
- COVID-19
- standard of care for COVID-19 as per the hospital guidelines
- Quercetin Phytosome (QP)
-
Lahore, Punjab, PakistanKing Edward Medical University Teaching Hospital
Jan 23, 2022
Fanconi Anemia Trial in Cincinnati (Quercetin (dietary supplement))
Active, not recruiting
- Fanconi Anemia
- Quercetin (dietary supplement)
-
Cincinnati, OhioCincinnati Children's Hospital Medical Center
Jan 3, 2022
Fanconi Anemia, Squamous Cell Carcinoma Trial in Cincinnati (Quercetin (dietary supplement))
Recruiting
- Fanconi Anemia
- Squamous Cell Carcinoma
- Quercetin (dietary supplement)
-
Cincinnati, OhioCincinnati Children's Hospital Medical Center
Feb 1, 2022
Coronary Artery Disease Trial in Montréal (Quercetin, Placebo)
Recruiting
- Coronary Artery Disease
- Quercetin
- Placebo
-
Montréal, Quebec, CanadaMontreal Heart Institute
Apr 4, 2022
a Randomized Double-blind Study, Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), PHYTOTHERAPIE Trial in Sahloul
Completed
- a Randomized Double-blind Study
- +2 more
- Quercetin
-
Sahloul, Sousse, TunisiaRiadh Boukef
Jan 2, 2023
Covid-19 Trial in Jamshoro (Complementary therapy, Standard of care)
Completed
- Covid-19
- Complementary therapy
- Standard of care
-
Jāmshoro, Sindh, PakistanLiaquat University Hospital
Mar 22, 2022